3rd Quarter - Report
THE SMITH-FREE GROUP, LLC for TEVA PHARMACEUTICALS USA, INC.
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 2853 BLOCKING Act of 2021 (All sections of full text) Discussions regarding the approval of generic drugs Monitored H.R.5376, Build Back Better Act Monitored the implementation of P.L.117-7, To prevent across-the-board direct spending cuts, and for other purposes Monitored Medicare and prescription drug changes
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK S DEUSER | — |
| JAMES C FREE | — |
| MICHAEL A. GAFFIN | — |
| ROBERT HICKMOTT | — |
| TREVOR W. KOLEGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.